• 1.

    Janda JM, Abbott SL, 2010. The genus Aeromonas: taxonomy, pathogenicity, and infection. Clin Microbiol Rev 23: 3573.

  • 2.

    Harris RL, Fainstein V, Elting L, Hopfer RL, Bodey GP, 1985. Bacteremia caused by Aeromonas species in hospitalized cancer patients. Rev Infect Dis 7: 314320.

    • Search Google Scholar
    • Export Citation
  • 3.

    Gold WL, Salit IE, 1993. Aeromonas hydrophila infections of skin and soft tissue: report of 11 cases and review. Clin Infect Dis 16: 6974.

    • Search Google Scholar
    • Export Citation
  • 4.

    Ko WC, Lee HC, Chuang YC, Liu CC, Wu JJ, 2000. Clinical features and therapeutic implications of 104 episodes of monomicrobial Aeromonas bacteraemia. J Infect 40: 267273.

    • Search Google Scholar
    • Export Citation
  • 5.

    Duthie R, Ling TW, Cheng AF, French GL, 1995. Aeromonas septicaemia in Hong Kong species distribution and associated disease. J Infect 30: 241244.

    • Search Google Scholar
    • Export Citation
  • 6.

    Kelly KA, Koehler JM, Ashdown LR, 1993. Spectrum of extraintestinal disease due to Aeromonas species in tropical Queensland, Australia. Clin Infect Dis 16: 574579.

    • Search Google Scholar
    • Export Citation
  • 7.

    Vally H, Whittle A, Cameron S, Dowse GK, Watson T, 2004. Outbreak of Aeromonas hydrophila wound infections associated with mud football. Clin Infect Dis 38: 10841089.

    • Search Google Scholar
    • Export Citation
  • 8.

    Janda JM, Guthertz LS, Kokka RP, Shimada T, 1994. Aeromonas species in septicemia: laboratory characteristics and clinical observations. Clin Infect Dis 19: 7783.

    • Search Google Scholar
    • Export Citation
  • 9.

    Soussy CJ, 2010. Antibiogram Committee of the French Society for Microbiology. French Society for Microbiology. Available at: www.sfm.asso.fr.

    • Search Google Scholar
    • Export Citation
  • 10.

    French GL, Cheng AF, Duthie R, Cockram CS, 1990. Septicaemia in Hong Kong. J Antimicrob Chemother 25 (Suppl C): 115125.

  • 11.

    Millership SE, Curnow SR, Chattopadhyay B, 1983. Faecal carriage rate of Aeromonas hydrophila. J Clin Pathol 36: 920923.

  • 12.

    Sautour M, Mary P, Chihib NE, Hornez JP, 2003. The effects of temperature, water activity and pH on the growth of Aeromonas hydrophila and on its subsequent survival in microcosm water. J Appl Microbiol 95: 807813.

    • Search Google Scholar
    • Export Citation
  • 13.

    Fardet L, Genereau T, Poirot JL, Guidet B, Kettaneh A, Cabane J, 2007. Severe strongyloidiasis in corticosteroid-treated patients: case series and literature review. J Infect 54: 1827.

    • Search Google Scholar
    • Export Citation
  • 14.

    Thomas L, Tyburn B, Bucher B, Pecout F, Ketterle J, Rieux D, Smadja D, Garnier D, Plumelle Y, 1995. Prevention of thromboses in human patients with Bothrops lanceolatus envenoming in Martinique: failure of anticoagulants and efficacy of a monospecific antivenom. Research Group on Snake Bites in Martinique. Am J Trop Med Hyg 52: 419426.

    • Search Google Scholar
    • Export Citation
  • 15.

    Easow JM, Tuladhar R, 2007. Aeromonas hydrophila wound infection following a tiger bite in Nepal. Southeast Asian J Trop Med Public Health 38: 867870.

    • Search Google Scholar
    • Export Citation
  • 16.

    Royle JA, Isaacs D, Eagles G, Cass D, Gilroy N, Chen S, Malouf D, Griffiths C, 1997. Infections after shark attacks in Australia. Pediatr Infect Dis J 16: 531532.

    • Search Google Scholar
    • Export Citation
  • 17.

    Koehler JM, Ashdown LR, 1993. In vitro susceptibilities of tropical strains of Aeromonas species from Queensland, Australia, to 22 antimicrobial agents. Antimicrob Agents Chemother 37: 905907.

    • Search Google Scholar
    • Export Citation
  • 18.

    Walsh TR, Stunt RA, Nabi JA, MacGowan AP, Bennett PM, 1997. Distribution and expression of beta-lactamase genes among Aeromonas spp. J Antimicrob Chemother 40: 171178.

    • Search Google Scholar
    • Export Citation
  • 19.

    Ko WC, Yu KW, Liu CY, Huang CT, Leu HS, Chuang YC, 1996. Increasing antibiotic resistance in clinical isolates of Aeromonas strains in Taiwan. Antimicrob Agents Chemother 40: 12601262.

    • Search Google Scholar
    • Export Citation
  • 20.

    Ko WC, Wu HM, Chang TC, Yan JJ, Wu JJ, 1998. Inducible beta-lactam resistance in Aeromonas hydrophila: therapeutic challenge for antimicrobial therapy. J Clin Microbiol 36: 31883192.

    • Search Google Scholar
    • Export Citation
  • 21.

    Lau SM, Peng MY, Chang FY, 2000. Outcomes of Aeromonas bacteremia in patients with different types of underlying disease. J Microbiol Immunol Infect 33: 241247.

    • Search Google Scholar
    • Export Citation
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

 

 

 

Bacteremia Caused by Aeromonas hydrophila Complex in the Caribbean Islands of Martinique and Guadeloupe

View More View Less
  • Department of Infectious and Tropical Disease, and Department of Bacteriology, Fort de France Teaching Hospital, Martinique, France; Department of Infectious and Tropical Disease, and Department of Bacteriology, Pointe à Pitre Teaching Hospital, Guadeloupe, France
Restricted access

Aeromonas species are Gram-negative bacilli of the water environment whose survival appears facilitated by warm climates. There have been no reports on Aeromonas hydrophila complex (A. hydrophila, A. caviae, A. veronii) in the Caribbean to date. Our aim was to describe clinical and bacteriological features in patients presenting with such bacteremia in Martinique and Guadeloupe. During a 14-year period, we retrospectively identified 37 patients. The mean age was 55 years and in 89% of cases underlying disease such as digestive diseases, cutaneous wounds, and malignancy were identified. One case was related to severe strongyloidiasis and one with snake bite. Polymicrobial bacteremia was identified in 38%, essentially with Enterobacteriaceae. All Aeromonas isolates were resistant to amoxicillin but extended-spectrum beta-lactam and fluoroquinolone were active against more than 95%. During hospitalization 10 patients died (27%). Older age, occurrence of multiorgan failure, and impaired renal function were associated with in-hospital mortality.

Author Notes

*Address correspondence to Patrick Hochedez, Service de Maladies Infectieuses et Tropicales, Centre Hospitalier Universitaire de Fort de France, BP 632, 97261 Fort de France, Martinique, France. E-mail: patrick.hochedez@chu-fortdefrance.fr

Authors' addresses: Patrick Hochedez and André Cabié, Service de Maladies Infectieuses et Tropicales, Centre Hospitalier Universitaire de Fort de France, Fort de France, Martinique, France, E-mails: patrick.hochedez@chu-fortdefrance.fr and andre.cabie@chu-fortdefrance.fr. Emilie Hope-Rapp and Gilles Beaucaire, Service de Maladies Infectieuses et Tropicales, Centre Hospitalier Universitaire de Pointe à Pitre/Abymes, Pointe-à-Pitre, Guadeloupe, France, E-mails: emilie.hope-rapp@chu-guadeloupe.fr and gilles.beaucaire@chu-guadeloupe.fr. Claude Olive, Service de Bactériologie, Centre Hospitalier Universitaire de Fort de France, Fort de France, Martinique, France, E-mail: claude.olive@chu-fortdefrance.fr. Muriel Nicolas, Service de Bactériologie, Centre Hospitalier Universitaire de Pointe-à-Pitre/Abymes, Pointe-à-Pitre, Guadeloupe, France, E-mail: muriel.nicolas@chu-guadeloupe.fr.

Save